Danaher Corporation (NYSE: DHR) is a global science and technology conglomerate with more than 20 operating companies.

IYH: Diversified Healthcare ETF Suitable For Short Term Investment

04:24am, Tuesday, 03'rd May 2022 Seeking Alpha
The IYH ETF has posted strong price returns over the medium and long term, but generated 1% yield. Read why I'll prefer to make IYH a trading instrument.
Danaher posted a temporary weakness on its topline growth which snowballed to its margins. It enjoys opportunities outside the pandemic which will support its topline growth.

2 Reasons to Buy Thermo Fisher Scientific, and 1 Reason to Sell

09:55am, Thursday, 28'th Apr 2022 The Motley Fool
The life sciences giant could end up being a victim of its own success.

Analyst Ratings for Danaher

07:00pm, Monday, 25'th Apr 2022 Benzinga
Danaher (NYSE:DHR) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 2 0 0 Last 30D 0 0 1 0

Top Analyst Reports for Alphabet, Amazon & Chevron

06:15pm, Monday, 25'th Apr 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Amazon.com, Inc. (AMZN), and Chevron Corporation (CVX).
Upgrades RBC Capital upgraded the previous rating for United States Steel Corp (NYSE:X) from Sector Perform to Outperform. United States Steel earned $3.64 in the fourth quarter, compared to $0.27 in
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read this week's edition.
"Danaher is a gift horse down here. Don't look it in the mouth, just take it," the "Mad Money" host said Friday.
The "Mad Money" host explained why investors should act fast to purchase Danaher stock on Friday's episode of the show.
Danaher Corporation (NYSE:DHR) had several weeks of downward pressure on the price. The stock appears to have consolidated in the range between $262 and $297. Currently, the stock is trading at $276.

All You Need to Know About Danaher (DHR) Rating Upgrade to Buy

04:00pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Danaher Corporation (NYSE:DHR) had several weeks of downward pressure on the price. The stock appears to have consolidated in the range between $262 and $297.
Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
We expect some noise around Covid testing quarter to continue as we work through China lockdowns, we think it's a distraction from Danaher's long-term story.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE